Implementing an Adolescent and Young Adult (AYA) mHealth Vaping Cessation Program Into Oncology Clinics
Launched by ST. JUDE CHILDREN'S RESEARCH HOSPITAL · Jul 28, 2023
Trial Information
Current as of July 23, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on understanding how young adults and adolescents who are survivors of childhood cancer use e-cigarettes, commonly known as vaping, and their interest in quitting. The study aims to explore various factors that may influence their vaping behaviors, including their age, gender, race, and experiences related to their cancer treatment. By gathering this information, the researchers hope to develop and improve a mobile health program designed to help these survivors quit vaping.
To participate in the trial, individuals must be between the ages of 13 and 24, have been treated for cancer, and be currently followed by St. Jude Children's Research Hospital. Participants will be asked about their vaping habits and can expect to engage in discussions that help shape the vaping cessation program. The trial is currently recruiting participants and aims to create a supportive environment for young cancer survivors to address their vaping behaviors.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Study Participants
- • Research participant is 13 to 24 years old at enrollment
- • Research participant is followed by St. Jude Children's Research Hospital (SJCRH)
- • Research participant has a diagnosis of malignancy or a CNS neoplasm
- • Research participant has been identified by the Transition Oncology Program (TOP) as a patient transitioning off active cancer therapy and/or followed by After Completion of Therapy (ACT) Clinic, and/or participating in the St. Jude Lifetime Cohort Study (SJLIFE)
- • Research participant is in remission and at least 3 months from having completed cancer-directed therapy
- • Participant can speak and read English
- • Healthcare Providers
- • Engaged in the healthcare of survivors seen through TOP, ACT, or SJLIFE
- Exclusion Criteria:
- • Study Participants
- • Significant psychiatric or neurologic disorders that would impair compliance with study protocol as indicated by the medical chart
About St. Jude Children's Research Hospital
St. Jude Children's Research Hospital is a premier pediatric research institution dedicated to advancing the treatment and understanding of catastrophic diseases in children, particularly cancer and other life-threatening conditions. Renowned for its innovative clinical trials and cutting-edge research, St. Jude integrates patient care with scientific discovery to develop new therapies and improve outcomes for young patients. The hospital is committed to ensuring that no family receives a bill for treatment, travel, housing, or food, fostering a holistic approach to pediatric care. Through collaboration with global research networks, St. Jude aims to share its findings and expertise to enhance treatment options worldwide, making significant strides in pediatric medicine.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Memphis, Tennessee, United States
Patients applied
Trial Officials
Rachel Webster, PhD
Principal Investigator
St. Jude Children's Research Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported